Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.

Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

For the year, the company reported profit of $5.98 billion, or $25.68 per share. Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per share.

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $501.00. The company’s shares closed ...

U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. Elevance Health led the insurance sector higher after it beat Wall Street’s sales and profit targets and raised its dividend.

Alaska Air Group ( ALK) shares climbed when the airline also topped profit and sales forecasts after it completed its acquisition of Hawaiian Airlines. While Alaska Air advanced, shares of American Airlines ( AAL) plunged as the carrier predicted its first-quarter loss would be more than expected and warned of higher costs.

The main US stock measures were mostly pointing lower before Thursday's opening bell as traders await the latest round of corporate earnings. Standard & Poor's 500 declined 0.2% and the Nasdaq was off 0.

Wall Street's main indexes were mixed on Thursday as investors assessed corporate earnings and awaited comments from President Donald Trump to gauge what his trade policy might look like. JPMorgan Chase and Goldman Sachs rose more than 1% each,

The benchmark S&P 500 rose to a record closing high on Thursday, as investors assessed a mixed bag of corporate earnings and digested comments from President Donald Trump, including a call for cuts in interest rates and oil prices.

Health-care companies rose sharply amid strong earnings.

Premium revenue is expected to rise in the low double-digit percentage range, while product revenue rises in the low single-digit range and service fees come in flat year-over-year. Overall, operating revenue should climb in the high-single to low-double-digit range.